October 21
- October 23
KCAS Bio will be attending the AusBiotech International Conference 2026, taking place October 21st–23rd at the Gold Coast Convention & Exhibition Centre in Queensland. As Australia’s largest life sciences conference, AusBiotech brings together the life sciences community to connect people, ideas, and opportunities. The conference provides a platform…
Blogs
Accurate pharmacokinetic data starts with confidence that the concentration measured by LC-MS/MS truly reflects what was present in the biological sample at the time of collection. For some small molecules, maintaining that integrity can be challenging. Structural features such as esters, lactones, aldehydes, and thiols may make a compound…
News
KCAS Bio’s Ryan Darling, Associate Director of Mass Spectrometry Bioanalysis, will present at the SCIEX Summit 2026 on Wednesday, October 7, as part of Day 2 of the virtual event. Advancing Ultrasensitive Bioanalysis for Complex Modalities Ryan’s presentation, “Ultrasensitive multiplexed bioanalysis of complex modalities using the SCIEX 7500+…
News
KCAS Bio’s Rathna Veeramachaneni, PhD, will join the 4th Annual Virtual Phenomenex BioSymposium on September 15, sharing insights into advanced LC–MS/MS approaches for the bioanalysis of complex antibody conjugates. Advancing Bioanalysis for Complex Antibody Conjugates Rathna’s presentation, “Magnetic Bead-Enabled Hybrid and Enhanced Traditional LC–MS/MS Workflows for the Bioanalysis…
October 11
- October 14
KCAS Bio will be attending the 27th North American Meeting of the International Society for the Study of Xenobiotics (ISSX), taking place October 11-14, 2026, in San Francisco, California. The 2026 meeting, themed “Back to the Future: DMPK Foundations and New Concepts,” will bring together scientists and researchers…
December 12
- December 15
The 68th ASH Annual Meeting and Exposition brings together the global hematology community to explore the latest advances in classical and malignant hematology. The meeting features hundreds of scientific and educational sessions covering basic, translational, clinical, and epidemiological research, providing attendees with opportunities to engage with emerging discoveries and…
September 17
- September 17
The MAFCA Annual Research Day brings together flow cytometry professionals for a full day of scientific presentations, research updates, and networking. The program features industry experts and multiple discussion tracks focused on the latest advancements, emerging research areas, and innovations in flow cytometry. Connect With Us at MAFCA…
October 1
- October 1
This workshop brings together industry experts and FDA perspectives to examine the key preclinical, bioanalytical, regulatory, and development considerations for successful IND filings for antibody-based therapeutics. Discussions will cover antibodies, antibody-drug conjugates, and multispecific antibodies, with topics ranging from pharmacology, PK/PD, bioanalysis, and toxicology to CMC activities, clinical development…
Blogs
Choosing between conventional and spectral flow cytometry and understanding exactly how the data travels from instrument to regulated reportable, has become one of the highest-leverage decisions in a biomarker program. The move to spectral flow is the most visible instrument shift of the past decade, but the harder…
Blogs
The companion animal health industry continues to experience significant growth as pet ownership rises, veterinary medicine advances, and owners increasingly seek innovative treatment options for their animals. Alongside this growth, sponsors developing pharmaceuticals, biologics, diagnostics, and other veterinary health products are navigating a rapidly evolving research environment. As…
Blogs
If an analyte is amenable to analysis, it’s difficult to ignore the benefits that LC-MS/MS can provide. There are numerous chaAntibody-drug conjugates (ADCs) have become one of the fastest growing classes of targeted therapeutics. By combining the specificity of monoclonal antibodies with highly potent cytotoxic payloads, ADCs are designed…
Posters & Papers
This paper, a collaboration between SCIEX and KCAS Bio, presents comprehensive LC-MS workflows for the quantitative analysis of antibody-drug conjugates (ADCs). Using trastuzumab deruxtecan as a model ADC, the study demonstrates sensitive quantification of free payload, total antibody, and conjugated ADC, highlighting the analytical performance and broad dynamic…